TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Net premium income has been realized | 13.37%9.47B | 7.32%17.51B | 1.33%8.35B | -52.62%16.32B | -52.21%8.24B | 3.35%34.44B | 6.91%17.25B | 2.20%33.33B | 3.30%16.13B | 2.19%32.61B |
-Net premium income | 13.37%9.47B | 7.32%17.51B | 1.33%8.35B | -52.62%16.32B | -52.21%8.24B | 3.35%34.44B | 6.91%17.25B | 2.20%33.33B | 3.30%16.13B | 2.19%32.61B |
-Including:Total premium income | 13.37%9.47B | 7.32%17.51B | 1.33%8.35B | -56.04%16.32B | -55.71%8.24B | 3.75%37.12B | 7.77%18.61B | 2.88%35.78B | 3.48%17.27B | 2.64%34.78B |
-Including: Premium | ---- | ---- | ---- | ---- | ---- | -9.26%-2.68B | -19.91%-1.36B | -13.20%-2.45B | -6.17%-1.14B | -10.06%-2.17B |
Investment income | ---- | ---- | ---- | ---- | ---- | -23.70%12.75B | 100.53%6.78B | 16.43%16.71B | -60.27%3.38B | 251.97%14.35B |
Special items of income | 61.12%2.19B | 1,822.00%2.58B | 207.18%1.36B | -145.05%-150M | -863.25%-1.27B | 2.78%333M | 10.67%166M | 15.30%324M | 1.35%150M | -8.47%281M |
Total income | 20.05%11.66B | 24.29%20.1B | 39.21%9.71B | -65.98%16.17B | -71.17%6.98B | -5.63%47.53B | 23.04%24.19B | 6.60%50.36B | -19.00%19.66B | 30.15%47.24B |
Net payments and claims | 13.51%-320M | -151.72%-572M | -130.78%-370M | 103.68%1.11B | 107.48%1.2B | 13.48%-30.06B | -23.32%-16.07B | -8.13%-34.74B | 17.99%-13.03B | -30.62%-32.13B |
-Special items of payment and claims | 13.51%-320M | -151.72%-572M | -130.78%-370M | 103.68%1.11B | 107.48%1.2B | 13.48%-30.06B | -23.32%-16.07B | -8.13%-34.74B | 17.99%-13.03B | -30.62%-32.13B |
Insurance business expenses and other expenses | -14.37%-7.57B | -12.17%-14.69B | -5.62%-6.62B | -45.70%-13.1B | -42.00%-6.27B | -7.90%-8.99B | -8.64%-4.41B | -5.76%-8.33B | -7.29%-4.06B | -4.62%-7.88B |
-Commission and handling fee expenses | ---- | ---- | ---- | ---- | ---- | -4.43%-4.6B | -5.10%-2.27B | -2.78%-4.4B | -5.89%-2.16B | -3.55%-4.28B |
-Financial expenses - expenses | -15.86%-263M | -20.26%-463M | -26.11%-227M | -7.84%-385M | -2.27%-180M | -22.26%-357M | -23.08%-176M | -3.18%-292M | -5.15%-143M | -24.12%-283M |
-Special items of operating payout | -2.13%-862M | 2.90%-1.81B | -13.90%-844M | 53.88%-1.86B | 62.37%-741M | -10.94%-4.04B | -11.81%-1.97B | -9.84%-3.64B | -9.24%-1.76B | -4.61%-3.31B |
Total payment、 claims and expenses | -12.90%-7.89B | -27.28%-15.27B | -38.00%-6.99B | 69.28%-11.99B | 75.28%-5.06B | 9.35%-39.05B | -19.83%-20.48B | -7.66%-43.07B | 13.13%-17.09B | -24.53%-40.01B |
Operating profit | 38.41%3.77B | 15.71%4.83B | 42.42%2.72B | -50.76%4.18B | -48.49%1.91B | 16.36%8.48B | 44.32%3.71B | 0.72%7.29B | -44.10%2.57B | 73.50%7.24B |
Attributable share of joint ventures and joint ventures | 171.57%73M | -120.66%-267M | 11.30%-102M | -1,000.00%-121M | -5,850.00%-115M | 35.29%-11M | 0.00%2M | -112.50%-17M | --2M | ---8M |
Earning before tax | 46.59%3.84B | 12.58%4.56B | 45.85%2.62B | -52.13%4.05B | -51.62%1.8B | 16.48%8.47B | 44.29%3.71B | 0.59%7.27B | -44.06%2.57B | 73.31%7.23B |
Tax | -42.62%-522M | -13.64%-783M | -46.99%-366M | 30.47%-689M | 44.04%-249M | 33.53%-991M | -13.81%-445M | -23.33%-1.49B | 45.62%-391M | -28.07%-1.21B |
After-tax profit from continuing operations | 47.23%3.32B | 12.36%3.78B | 45.67%2.26B | -55.00%3.37B | -52.65%1.55B | 29.38%7.48B | 49.75%3.27B | -3.97%5.78B | -43.77%2.18B | 86.55%6.02B |
Earning After tax | 47.23%3.32B | 12.36%3.78B | 45.67%2.26B | -55.00%3.37B | -52.65%1.55B | 29.38%7.48B | 49.75%3.27B | -3.97%5.78B | -43.77%2.18B | 86.55%6.02B |
Minority profit | 20.00%6M | -50.00%17M | 0.00%5M | -32.00%34M | -79.17%5M | --50M | 271.43%24M | --0 | -177.78%-14M | -38.10%39M |
Profits attributable to shareholders | 47.29%3.31B | 13.00%3.76B | 45.82%2.25B | -55.15%3.33B | -52.45%1.54B | 28.52%7.43B | 47.70%3.25B | -3.35%5.78B | -43.14%2.2B | 89.03%5.98B |
Basic earnings per share | 57.89%0.3 | 17.86%0.33 | 46.15%0.19 | -54.84%0.28 | -51.85%0.13 | 29.17%0.62 | 50.00%0.27 | -4.00%0.48 | -43.75%0.18 | 92.31%0.5 |
Diluted earnings per share | 57.89%0.3 | 17.86%0.33 | 46.15%0.19 | -54.10%0.28 | -51.85%0.13 | 27.08%0.61 | 50.00%0.27 | -4.00%0.48 | -43.75%0.18 | 92.31%0.5 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | IAS and HKAS | IAS and HKAS | IAS and HKAS | IAS and HKAS | IAS and HKAS | IAS and HKAS | IAS and HKAS | IAS and HKAS | IAS and HKAS | IAS and HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.